NewLeaf Symbiotics Funding
$0
22 rounds
NewLeaf Symbiotics is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on September 15, 2014.
Funding Rounds
B
$17000000Series BSep 2014
A
$7000000
Investors of NewLeaf Symbiotics
Otter Capital
Rounds
C
Lewis & Clark Ventures
A St. Louis-based venture capital firm focusing on the Midwest
Rounds
C
General Partner at Pangaea Ventures, formerly President of BASF Venture Capital America and before that with Mitsubishi Corporation. Award winning musician.
Pangaea Ventures
Rounds
C
B
A
Open Prairie Ventures
Rounds
B
A
RockPort Capital Partners
Rounds
B
Palo Alto Investors
Rounds
B
Leading fund focused on Energy, Mobility, and Sustainability
Rounds
C
A